✦ LIBER ✦

The Effect of Age on the Efficacy of Maintenance Bacillus Calmette-Guérin Relative to Maintenance Epirubicin in Patients with Stage Ta T1 Urothelial Bladder Cancer: Results from EORTC Genito-Urinary Group Study 30911

✍ Scribed by Oddens, Jorg R.; Sylvester, Richard J.; Brausi, Maurizio A.; Kirkels, Wim J.; van de Beek, Cees; van Andel, George; de Reijke, Theo M.; Prescott, Stephen; Witjes, J. Alfred; Oosterlinck, Willem

Book ID: 127377406
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 593 KB
Volume: 66
Category: Article
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2014.05.033

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-Term Efficacy Results of EORTC Geni

Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

✍ Richard J. Sylvester; Maurizio A. Brausi; Wim J. Kirkels; Wolfgang Hoeltl; Ferna 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 408 KB

Re: Long-Term Efficacy Results of EORTC

Re: Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

✍ Donald L. Lamm 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Re: Long-Term Efficacy Results of EORTC

Re: Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin Plus Isoniazid in Patients With Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

✍ Wood, David P. 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 52 KB

PROGNOSTIC FACTORS IN PATIENTS WITH INTE

PROGNOSTIC FACTORS IN PATIENTS WITH INTERMEDIATE AND HIGH RISK STAGE TA T1 PAPILLARY CARCINOMA OF THE BLADDER TREATED WITH MAINTENANCE EPIRUBICIN OR MAINTENANCE BACILLUS CALMETTE-GUERIN. RESULTS OF EORTC GU GROUP STUDY 30911

✍ R.J. Sylvester; W. Oosterlinck; M.A. Brausi; W.J. Kirkels; F. Calais Da Silva; T 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 70 KB

PROGNOSTIC FACTORS IN PATIENTS WITH INTE

PROGNOSTIC FACTORS IN PATIENTS WITH INTERMEDIATE AND HIGH RISK STAGE Ta T1 PAPILLARY CARCINOMA OF THE BLADDER TREATED WITH MAINTENANCE EPIRUBICIN OR MAINTENANCE BACILLUS CALMETTE-GUERIN. RESULTS OF EORTC GU GROUP STUDY 30911

✍ Sylvester, Richard; Oosterlinck, Willem; Brausi, Maurizio; Kirkels, Wim J; Da Si 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 146 KB

659 EFFECT OF AGE ON TREATMENT OUTCOME A

659 EFFECT OF AGE ON TREATMENT OUTCOME AND TOLERANCE IN PATIENTS WITH STAGE TA T1 PAPILLARY CARCINOMA OF THE BLADDER TREATED WITH MAINTENANCE BACILLUS CALMETTEGUERIN: RESULTS OF EORTC GU GROUP STUDY 30911

✍ R.J. Sylvester; M.A. Brausi; W.J. Kirkels; J. Oddens; W. Hoeltl; G. Van Andel; T 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 506 KB